R3 stem cell treatment will help you recover from injuries and diseases without going into surgeries. When we talk about stem cell therapy, R3 is a pioneer of the stem cell industry. At present, Dr. Greene's R3 stem cell is the global leader in regenerative cell therapies.
Adult Stem cells in Orthopaedics present and future perspectives.
Παρουσίαση του Δρ. Σταύρου Αλευρογιάννη που έγινε στο ξενοδοχείο Χίλτον, στις 12/06/15 στα πλαίσια Ημερίδας της Ελληνικής Εταιρείας Αναγεννητικής Ιατρικής, Αντιγήρανσης και Βιοτεχνολογίας, στο 41ο Πανελλήνιο Ιατρικό Συνέδριο.
"H θέση της αναγεννητική Ιατρικής στις παθήσεις Οστών και Αρθρώσεων"
Regenerative medicine is now an recognized specialty which has evolved from degerative diseases of Orthopaedic Surgery.Orthobiologics is a current terminology for the application of various cells, cytokines, growth factors.Busy people find it to update and this is an update.
Adult Stem cells in Orthopaedics present and future perspectives.
Παρουσίαση του Δρ. Σταύρου Αλευρογιάννη που έγινε στο ξενοδοχείο Χίλτον, στις 12/06/15 στα πλαίσια Ημερίδας της Ελληνικής Εταιρείας Αναγεννητικής Ιατρικής, Αντιγήρανσης και Βιοτεχνολογίας, στο 41ο Πανελλήνιο Ιατρικό Συνέδριο.
"H θέση της αναγεννητική Ιατρικής στις παθήσεις Οστών και Αρθρώσεων"
Regenerative medicine is now an recognized specialty which has evolved from degerative diseases of Orthopaedic Surgery.Orthobiologics is a current terminology for the application of various cells, cytokines, growth factors.Busy people find it to update and this is an update.
A less-invasive-approach-of-medial-meniscectomy-in-rat-a-model-to-target-earl...science journals
The existing medial meniscectomy (MMx) procedure in rodents involves transection of MCL and wide opening of the knee capsule followed by meniscus transection.
Cartilage Repair using Stem cell & OrthobiologicsVaibhav Bagaria
Regenerating Cartilage is a challenge. What's new in this field of cartilage regeneration and the current status of the stem cell use in this field is described.
Bone and Cartilage regeneration with cells and tissue engineering products - ...Enric Caceres
Bone and Cartilage regeneration with cells and tissue engineering products - Dr. Enric Cáceres - B-Debate 17/02/2015 http://www.bdebate.org/en/forum/advanced-therapies-and-regenerative-medicine-promise-21st-century
An update on stem cell technologies, prp and orthobiologics. Nuffield Health, The Grosvenor Hospital Chester and Chester Knee Clinic GP Seminar, Ewloe, Wales, UK 6th May 2017
Musculoskeletal disorders
includes the following disorders:
Bone infections: Osteomyelitis, and Septic arthritis; Disorders of foot:
Hallux valgus (bunions), Morton’s neuroma (plantar neuroma), and
Hammer toe; Muscular disorders:
Muscular dystrophy, and Rhabdomyolysis
There are more than 100 kinds of arthritis, which literally means joint inflammation. According to the Centers for Disease Control and Prevention (CDC), about 50 million Americans are afflicted, and 27 million have osteoarthritis, by far the most common form, especially among older people.
A less-invasive-approach-of-medial-meniscectomy-in-rat-a-model-to-target-earl...science journals
The existing medial meniscectomy (MMx) procedure in rodents involves transection of MCL and wide opening of the knee capsule followed by meniscus transection.
Cartilage Repair using Stem cell & OrthobiologicsVaibhav Bagaria
Regenerating Cartilage is a challenge. What's new in this field of cartilage regeneration and the current status of the stem cell use in this field is described.
Bone and Cartilage regeneration with cells and tissue engineering products - ...Enric Caceres
Bone and Cartilage regeneration with cells and tissue engineering products - Dr. Enric Cáceres - B-Debate 17/02/2015 http://www.bdebate.org/en/forum/advanced-therapies-and-regenerative-medicine-promise-21st-century
An update on stem cell technologies, prp and orthobiologics. Nuffield Health, The Grosvenor Hospital Chester and Chester Knee Clinic GP Seminar, Ewloe, Wales, UK 6th May 2017
Musculoskeletal disorders
includes the following disorders:
Bone infections: Osteomyelitis, and Septic arthritis; Disorders of foot:
Hallux valgus (bunions), Morton’s neuroma (plantar neuroma), and
Hammer toe; Muscular disorders:
Muscular dystrophy, and Rhabdomyolysis
There are more than 100 kinds of arthritis, which literally means joint inflammation. According to the Centers for Disease Control and Prevention (CDC), about 50 million Americans are afflicted, and 27 million have osteoarthritis, by far the most common form, especially among older people.
Osteoartritis (OA) adalah salah satu jenis artritis yang paling sering dialami oleh sebagian orang. Penyakit ini merupakan penyakit sendi degeneratif yang mempengaruhi tulang rawan persendian. OA terjadi akibat rusaknya kartilago yang melindungi dan memberi bantalan bagi sendi.
These slides are for Yoga Teachers or students of Yoga for understanding the disease and what Yoga program we can offer to our client when they reach you for help. Although every individual is unique and Yoga Therapy should also be made considering what level of disease they are going through.
Disclaimer: We dont take any responsibility if someone starts to follow the program as mentioned in the PPT for any harm or injury.
Southland Arthritis is a group practice of Rheumatologists with offices in Hemet, Menifee, Moreno Valley and Temecula. Southland Arthritis has been treating patients throughout Southern California since 1983
Studying relation between sitting position and knee osteoarthritiiosrjce
Osteoarthritis (OA) of the knee is the most common form of arthritis and leads to more activity
limitations (e.g., disability in walking and stair climbing) than any other disease, especially in the elderly. The
aim of this study was to clarify the relationship between the sitting position and knee osteoarthritis. The study
involved fat males of knee pain and clinical diagnosis of early knee osteoarthritis this research is applied and
the research method is "descriptive-correlative". In order to collecting data was used questionnaire tool. Also,
in order to analyzing data was used statistical method such as Pierson coefficient and Chi-squared test. Data is
analyzed from both descriptive and inferential statistics. Descriptive statistics and graphs on the table will
describe the characteristics of the study sample. The researcher to analyze the hypotheses used Chi-square
method. The statistical society is Osteoarthritis disease males.
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareDr. David Greene Arizona
Explore the groundbreaking work of Dr. David Greene, a pioneer in regenerative medicine, who is revolutionizing the field of cardiology through stem cell therapy in Arizona. This ppt delves into how Dr. Greene's innovative approach is providing non-surgical, effective treatments for heart disease, using the body's own cells to repair heart damage and improve patient outcomes. Learn about the science behind stem cell therapy, its benefits over traditional cardiac surgeries, and the promising future it holds for modern medicine. Join us as we uncover how Dr. Greene's commitment to stem cell research and therapy is setting new standards in healthcare and offering new hope to cardiac patients.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Building the Future of Regenerative Medicine Dr. David Greene's Work with Ste...Dr. David Greene Arizona
The work of Dr. David Greene and his colleagues in Arizona is a testament to the potential of regenerative medicine to change lives. While there are still many hurdles to overcome, the dedication of researchers like Dr. Greene continues to light the way towards a future where stem cell therapy could offer new hope to patients around the globe. As we stand on the brink of medical revolutions, it is the pioneering spirit of individuals like Dr. Greene that will guide us into a healthier, more promising future.
Dr. David Greene Explores Stem Cell Therapies for Lung Disease Innovations in...Dr. David Greene Arizona
Dr. David Greene continues to explore and expand the boundaries of stem cell therapies for lung disease, the medical community watches eagerly. Innovations in pulmonary health could soon offer new, more effective ways to manage and treat chronic lung conditions, significantly improving the quality of life for millions of patients around the world
Turning the Tide on Infertility Dr. David Greene's Insights into Stem Cells f...Dr. David Greene Arizona
Stem cell therapy, championed by Dr. David Greene, represents a transformative approach to treating ovarian failure. By harnessing the body's innate ability to heal and regenerate, Dr. Greene's work could turn the tide on infertility, offering new hope to those who once thought their chances of motherhood were lost. As this exciting field evolves, it continues to hold the potential to redefine what is possible in medicine and fertility treatments.
The Science Behind Alleviating Back Pain: Insights from Dr. David Greene on S...Dr. David Greene Arizona
Stem cell therapy represents a significant leap forward in the treatment of back pain, offering hope to those who have suffered for years. With experts like Dr. David Greene at the forefront, patients have access to a treatment that is both innovative and rooted in a deep understanding of the body's own healing mechanisms. As this field advances, it may well redefine how we think about managing chronic pain and restoring function.
Dr. David Greene on the Effectiveness of Stem Cell Therapy in Treating Hair L...Dr. David Greene Arizona
Stem cell therapy presents a fascinating frontier in the treatment of hair loss, offering hope to many who have exhausted other options. Dr. David Greene’s expertise underscores the importance of continued research and patient education in this field. For those considering this treatment, consulting with knowledgeable specialists who can provide tailored advice is crucial.
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...Dr. David Greene Arizona
Dr. David Greene represents a significant leap forward in the fight against kidney diseases. Through his dedication to stem cell research, there is now a potential path to not just managing but curing these debilitating conditions. As this field of medicine evolves, it holds not only promise but also a testament to the power of scientific innovation and perseverance.
Healing with Innovation: Dr. David Greene’s Vision for a Healthier TomorrowDr. David Greene Arizona
Healing with Innovation" explores Dr. David Greene's revolutionary work in regenerative medicine, emphasizing his blend of cutting-edge science with deep compassion in patient care. This piece delves into how his visionary approach is not only advancing medical treatments but also transforming the healthcare system into one that truly prioritizes patient well-being.
Dr. David Greene's Guide to Healing: Unleashing PRP's Power on Blood Stem CellsDr. David Greene Arizona
Through the innovative work of Dr. David Greene and the dedicated team at R3 Stem Cell, PRP therapy is setting a new standard in regenerative medicine. By unlocking the power of blood stem cells, they are opening the door to healing possibilities that were once thought to be the realm of science fiction. As we look forward to the advancements that lie ahead, one thing is clear: the future of healing is bright, and it flows through our veins.
Dr. David Greene's Vision Leading the Charge in Diabetes Treatment with R3 St...Dr. David Greene Arizona
Dr. David Greene and R3 Stem Cell are at the forefront of diabetes treatment through innovative stem cell therapy. Their pioneering work aims to regenerate damaged tissues, potentially restoring normal insulin production. This breakthrough approach represents a significant leap forward, offering new hope to millions battling diabetes and exemplifying the power of scientific innovation in transforming patient care.
The Promise of Regeneration: Dr. David Greene Evaluates Stem Cell Therapies f...Dr. David Greene Arizona
Dr. David Greene's evaluation of stem cell therapies for stroke offers an exciting glimpse into the future of regenerative medicine. While there are challenges to be overcome, the potential benefits of these therapies could be transformative, offering new hope for recovery and rehabilitation for stroke survivors.
The Revolutionary Path of Dr. David Greene and the Future of Stem Cell Therap...Dr. David Greene Arizona
Dr. David Greene's contributions to stem cell research and regenerative medicine mark a pivotal chapter in the story of healing and human health. As we stand on the cusp of new medical breakthroughs, his work serves as both a foundation and a beacon, guiding the way toward a future where the full healing potential of stem cells is realized. For those of us following this journey, the possibilities are as limitless as the dedication of the researchers leading the charge.
The Science of Healing Dr. David Greene on Stem Cells for Burn Injuries (1).pptxDr. David Greene Arizona
The Science of Healing: Dr. David Greene explores the revolutionary use of stem cells in treating burn injuries. This innovative approach accelerates recovery, reduces scarring, and enhances the regeneration of healthy skin, promising a transformative leap forward in medical science and patient care.
Alzheimer’s Disease, Dementia, and Stem Cell Therapy Insights from Dr. David ...Dr. David Greene Arizona
Alzheimer’s Disease, Dementia, and Stem Cell Therapy: Insights from Dr. David Greene" delves into the innovative intersection of neurodegenerative disorders and regenerative medicine. Dr. Greene sheds light on cutting-edge research and the potential of stem cells to revolutionize Alzheimer's and dementia treatment, offering hope through scientific breakthroughs and expert analysis.
The Future of Joint Restoration Dr. David Greene and Advances in Stem Cell Th...Dr. David Greene Arizona
The future of joint restoration is bright with leaders like Dr. David Greene at the helm of advances in stem cell therapy for orthopedic conditions. By pushing the boundaries of regenerative medicine, they are not only enhancing our understanding of the body's healing capabilities but also improving the lives of patients worldwide.
Dr. David Greene's Arizona Breakthrough Stem Cell Therapy for Sclerosis.pptxDr. David Greene Arizona
Dr. David Greene's work in Arizona heralds a major advancement in treating sclerosis through stem cell therapy, offering new hope by harnessing the regenerative potential of stem cells to repair damaged tissues, significantly improving patient outcomes and potentially transforming the future of medical treatments for chronic diseases.
Dr. David Greene: At the Forefront of Stem Cell Solutions for Parkinson'sDr. David Greene Arizona
Dr. David Greene's work in stem cell therapy for Parkinson's disease represents a significant leap forward in the fight against neurodegenerative disorders. By pushing the boundaries of science and medicine, Dr. Greene not only offers hope to those directly affected by Parkinson's disease but also paves the way for future breakthroughs. As we continue to follow his progress, we are reminded of the power of innovation and the potential for science to change lives.
Dr. David Greene's pioneering work in stem cell therapy is more than just a medical advancement; it's a turning point in how we approach treating chronic back pain. With continued research and dedication, this therapy promises a future where back pain is no longer a lifelong burden but a treatable condition.
Dr. David Greene's contributions to stem cell therapy are not just scientific achievements; they are beacons of hope for millions of patients worldwide. As we stand on the cusp of a new era in medicine, his work reminds us of the power of innovation and the relentless pursuit of healing and recovery. The future of medicine is bright, and with pioneers like Dr. Greene, it's closer than ever.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
2. What is it?
Foot and ankle arthritis impedes movement and
motion, directly affecting the ability to walk
causing stiffness, redness, pain, and deformities.
Owing to the fact that each foot houses 28 bones
and over 30 joints, arthritis (meaning “disease or
inflammation of a joint”) can affect the foot and
ankles in a number of painful ways.
3. Three types of arthritis pose the
greatest danger to the foot and ankle:
osteoarthritis (degenerative arthritis),
rheumatoid arthritis, and
posttraumatic arthritis (considered
secondary osteoarthritis). Of these,
degenerative arthritis is the most
common, affecting most patients in
middle age but known to hit younger
people too.
4. A substance surrounds the
end of these bones, known as
articular cartilage that helps
the bones slide over each
other, facilitating movement.
This cartilage recedes due to
what is now a progressive
joint deterioration and is lost
over time, producing lumps of
bone around the joint, called
bone spurs.
5. What are
the
symptoms?
Since the affected body part
here is the foot, it is safe to
assume that the major
system of arthritis of the foot
and ankle should be a
difficulty to walk. Arthritis
patients have described the
feeling as “walking on
pebbles”. In fact, symptoms
can range from mild foot
related problems to a general
difficulty.
6. Namely, the symptoms of
foot and ankle arthritis are
joints feeling stiff, hot, tender,
painful, swelled, and
inflamed. Your range of
motion will also be widely
affected to the point of being
severely reduced, if not
impossible.
7. How is it diagnosed?
The diagnosis of arthritis is an extensive
process, drawing on the patient’s medical
history as well as physical tests, including
a gait analysis. Simply the way that a
patient might limp can help a doctor
ascertain the nature of your arthritis, right
down to the location.
8. The patient’s history will determine
the nature of injuries that might have
been sustained in the past. A detailed
discussion with the doctor can help to
get to the root of the symptoms,
including the symptoms being
experienced elsewhere as well.
9. However, there are surgical options
available as well. Even in the early
stages of arthritis, arthroscopic
debridement can be helpful.
Debridement, which essentially means
cleaning, targets the affected joint and
removes the bone spurs, inflamed
synovial tissue, and remnants of loose
cartilage.